source stringlengths 2 222 | date stringlengths 19 19 | url stringlengths 22 853 ⌀ | text stringlengths 0 10k ⌀ | title stringlengths 0 701 | context_id stringlengths 1 9 | document_id stringclasses 2
values | document_type stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Zacks Investment Research | 2023-07-19 13:37:27 | https://www.zacks.com/stock/news/2123962/will-amerisourcebergen-abc-beat-estimates-again-in-its-next-earnings-report | AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-07-17 14:18:20 | https://www.zacks.com/stock/news/2122316/amerisourcebergen-abc-is-an-incredible-growth-stock-3-reasons-why | AmerisourceBergen (ABC) could produce exceptional returns because of its solid growth attributes. | AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-07-17 11:18:16 | https://www.zacks.com/stock/news/2122083/is-amerisourcebergen-abc-a-great-value-stock-right-now | Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | Is AmerisourceBergen (ABC) a Great Value Stock Right Now? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-07-17 11:18:12 | https://www.zacks.com/stock/news/2122062/is-amerisourcebergen-abc-stock-outpacing-its-medical-peers-this-year | Here is how AmerisourceBergen (ABC) and Hologic (HOLX) have performed compared to their sector so far this year. | Is AmerisourceBergen (ABC) Stock Outpacing Its Medical Peers This Year? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-07-05 10:02:51 | https://www.zacks.com/stock/news/2116933/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2023-06-29 16:30:00 | https://www.businesswire.com/news/home/20230629779493/en/AmerisourceBergen-Announces-Date-and-Time-for-Third-Quarter-Fiscal-2023-Earnings-Release/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2023 on Wednesday, August 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the res... | AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-06-01 12:35:47 | https://www.zacks.com/stock/news/2102685/why-is-amerisourcebergen-abc-up-2-since-last-earnings-report | AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? | Why Is AmerisourceBergen (ABC) Up 2% Since Last Earnings Report? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-29 11:50:06 | https://www.zacks.com/stock/news/2100981/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Forbes | 2023-05-12 11:34:47 | https://www.forbes.com/sites/brucejapsen/2023/05/12/walgreens-sells-amerisourcebergen-shares-to-raise-694-million-to-pay-down-debt/ | Walgreens Boots Alliance has sold shares of AmerisourceBergen for proceeds of $694 million, which will be used "primarily for debt paydown and general corporate purposes." | Walgreens Sells AmerisourceBergen Shares To Raise $694 Million To Pay Down Debt | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-05 11:23:42 | https://www.zacks.com/stock/news/2090901/should-value-investors-buy-amerisourcebergen-abc-stock | Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | Should Value Investors Buy AmerisourceBergen (ABC) Stock? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-04 14:26:15 | https://www.zacks.com/stock/news/2090269/3-reasons-growth-investors-will-love-amerisourcebergen-abc | AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials. | 3 Reasons Growth Investors Will Love AmerisourceBergen (ABC) | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-03 11:27:24 | https://www.zacks.com/stock/news/2089014/is-amerisourcebergen-abc-outperforming-other-medical-stocks-this-year | Here is how AmerisourceBergen (ABC) and Align Technology (ALGN) have performed compared to their sector so far this year. | Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-02 16:51:13 | https://www.zacks.com/stock/news/2088476/amerisourcebergen-abc-beats-on-q2-earnings-ups-23-eps-view | AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin. | AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-02 09:08:21 | https://www.zacks.com/stock/news/2087888/amerisourcebergen-abc-beats-q2-earnings-and-revenue-estimates | AmerisourceBergen (ABC) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.22 per share a year ago. | AmerisourceBergen (ABC) Beats Q2 Earnings and Revenue Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2023-05-02 07:06:00 | https://www.marketwatch.com/story/amerisourcebergen-stock-pops-premarket-after-earnings-blow-past-estimates-62e3ea4c | AmerisourceBergen Corp.'s stock ABC rose 0.8% premarket Tuesday, after the pharmaceutical services company's fiscal second-quarter earnings blew past estimates. The company had net income of $435.4 million, or $2.13 a share, for the quarter to March 31, down from $548.0 million, or $2.59 a share, in the year-earlier pe... | AmerisourceBergen stock pops premarket after earnings blow past estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-26 12:11:31 | https://www.zacks.com/stock/news/2085156/amerisourcebergen-abc-to-post-q2-earnings-what-s-in-store | AmerisourceBergen's (ABC) fiscal 2023 second-quarter results are likely to reflect solid performance in the U.S. Healthcare Solutions segment. | AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-21 12:56:37 | https://www.zacks.com/stock/news/2082868/amerisourcebergen-s-abc-new-jv-to-boost-oncology-care | AmerisourceBergen's (ABC) new JV is expected to provide the independent community oncology network with additional resources and expertise to grow the platform and improve patient outcomes. | AmerisourceBergen's (ABC) New JV to Boost Oncology Care | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2023-04-20 08:43:00 | https://www.marketwatch.com/story/tpg-amerisourcebergen-to-oneoncology-in-a-deal-that-values-the-oncology-practices-network-at-2-1-billion-6b7955ba | Asset management firm TPG Inc. TPG, +3.12% and pharmaceutical services company AmerisourceBergen Corp. ABC, -1.75% announced Thursday an agreement to buy oncology practices network OneOncology from private equity firm General Atlantic in a deal that values OneOncology at $2.1 billion. After the deal closes, which is ex... | TPG, AmerisourceBergen to OneOncology in a deal that values the oncology practices network at $2.1 billion | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-19 12:56:48 | https://www.zacks.com/stock/news/2081413/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-04-07 13:14:55 | https://www.investors.com/news/5-sp-500-stocks-showing-strength-as-recession-fears-rise/ | Medical stocks are holding up amid economic and market uncertainty. The post 5 S&P 500 Stocks Showing Strength As Recession Fears Rise appeared first on Investor's Business Daily. | 5 S&P 500 Stocks Showing Strength As Recession Fears Rise | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2023-03-29 16:30:00 | https://www.businesswire.com/news/home/20230329005915/en/AmerisourceBergen-Announces-Date-and-Time-for-Second-Quarter-Fiscal-2023-Earnings-Release/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2023 on Tuesday, May 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results... | AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-03-29 14:15:55 | https://investorplace.com/2023/03/animal-spirits-are-returning-with-mixed-results/ | This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here. | Animal Spirits Are Returning | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-03-16 23:16:08 | https://investorplace.com/2023/03/7-stocks-to-buy-for-a-market-recovery/ | While time in the market generally beats out timing the market, it's understandable that some investors may want to hold off on looking for stocks to buy. After all, equities continue to digest the sudden failure of a handful of financial institutions. | 7 Stocks Set to Soar When the Market Recovers | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-15 12:14:11 | https://www.zacks.com/stock/news/2066229/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a concern. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-03-07 08:30:40 | https://seekingalpha.com/article/4585156-amerisourcebergen-strong-addition-to-any-portfolio | AmerisourceBergen Corporation is a strong company and leader in the industry it operates within, continuously offering value to shareholders by share buybacks. Revenues came in line with analysts in the last quarter and resulted in the company raising full-year guidance. | AmerisourceBergen: A Strong Addition To Any Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-27 14:18:16 | https://www.zacks.com/stock/news/2059443/3-reasons-why-growth-investors-shouldn-t-overlook-amerisourcebergen-abc | AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market. | 3 Reasons Why Growth Investors Shouldn't Overlook AmerisourceBergen (ABC) | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-27 11:17:38 | https://www.zacks.com/stock/news/2059307/are-investors-undervaluing-amerisourcebergen-abc-right-now | Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | Are Investors Undervaluing AmerisourceBergen (ABC) Right Now? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-02-19 02:13:52 | https://seekingalpha.com/article/4579809-dividend-champion-contender-and-challenger-highlights-week-of-february-19 | A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. | Dividend Champion, Contender, And Challenger Highlights: Week Of February 19 | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-17 09:02:08 | https://www.zacks.com/stock/news/2055747/5-stocks-to-keep-an-eye-on-following-upgrade-by-brokers | We believe that broker-favorite stocks like Archer Daniels (ADM), Delek US (DK), Beazer Homes (BZH), AmerisourceBergen (ABC) and Avnet (AVT) are worth a look. | 5 Stocks to Keep an Eye on Following Upgrade by Brokers | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-02-16 05:40:00 | https://www.fool.com/investing/2023/02/16/is-this-buffett-stock-a-buy-for-dividend-growth/ | This Buffett-backed business leads the medical distribution industry. | Is This Warren Buffett Stock a Buy for Dividend Growth Investors? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-07 11:19:10 | https://www.zacks.com/stock/news/2050952/should-value-investors-buy-amerisourcebergen-abc-stock | Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | Should Value Investors Buy AmerisourceBergen (ABC) Stock? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-03 11:17:55 | https://www.zacks.com/stock/news/2049579/here-s-why-amerisourcebergen-abc-is-a-strong-value-stock | Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. | Here's Why AmerisourceBergen (ABC) is a Strong Value Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-03 09:47:35 | https://www.zacks.com/commentary/2049396/5-dental-supplies-stocks-to-buy-amid-recovering-prospects | Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI. | 5 Dental Supplies Stocks to Buy Amid Recovering Prospects | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-02 09:47:43 | https://www.zacks.com/stock/news/2048208/amerisourcebergen-abc-q1-earnings-top-eps-view-raised | AmerisourceBergen's (ABC) fiscal first-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin. | AmerisourceBergen (ABC) Q1 Earnings Top, EPS View Raised | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-02-01 09:46:01 | https://seekingalpha.com/article/4574225-amerisourcebergen-corporation-abc-q1-2023-earnings-call-transcript | AmerisourceBergen Corporation (NYSE:ABC ) Q1 2023 Earnings Conference Call February 1, 2023 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head, Investor Relations & Treasury Steve Collis - Chairman, President, & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Of... | AmerisourceBergen Corporation (ABC) Q1 2023 Earnings Call Transcript | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-01 09:02:19 | https://www.zacks.com/stock/news/2047483/amerisourcebergen-abc-surpasses-q1-earnings-and-revenue-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of 3.44% and 0.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Surpasses Q1 Earnings and Revenue Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2023-02-01 06:59:00 | https://www.marketwatch.com/story/amerisourcebergen-corp-stock-rises-on-q1-top-line-beat-raised-guidance-01675252763 | AmerisourceBergen Corp.'s ABC, +2.21% stock rose 0.6% before market open Wednesday after the drug distribution giant reported first-quarter results that beat analysts' revenue expectations and raised its guidance. The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million, or $2.13 a shar... | AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-27 09:47:13 | https://www.zacks.com/stock/news/2045383/amerisourcebergen-abc-to-post-q1-earnings-what-s-in-store | AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment. | AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-25 12:02:06 | https://www.zacks.com/stock/news/2044177/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2023-01-24 09:14:00 | https://www.marketwatch.com/story/amerisourcebergen-to-change-name-to-cencora-later-this-year-01674569669 | AmerisourceBergen Corp. ABC, -0.30% said Tuesday it plans to change its name to Cencora in the second half of the year. The drug distribution giant said the new name reflects a “future-oriented mindset. | AmerisourceBergen to change name to Cencora later this year | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-14 04:24:09 | https://seekingalpha.com/article/4569938-amerisourcebergen-stock-screams-quality-at-15x-earnings-60-percent-roic | AmerisourceBergen caught a strong bid in the back end of FY22. Diving underneath the hood of its earnings reveals strong evidence of outsized profitability, adding to ABC's ability to create future value for shareholders. | AmerisourceBergen Screams Quality At 15x Earnings, 60% ROIC | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-01-06 07:00:24 | https://www.investors.com/etfs-and-funds/mutual-funds/recession-in-2023-top-fund-managers-dont-care/ | Want to know what the market will do in 2023? Is a recession coming? | Recession Coming? Don't Ask This Hot Fund's Managers | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-04 13:32:18 | https://www.zacks.com/stock/news/2035291/will-amerisourcebergen-abc-beat-estimates-again-in-its-next-earnings-report | AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-04 10:32:28 | https://www.zacks.com/stock/news/2035068/want-better-returns-don-t-ignore-these-2-medical-stocks-set-to-beat-earnings | Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP. | Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2023-01-03 16:30:00 | https://www.businesswire.com/news/home/20230103005465/en/AmerisourceBergen-Announces-Date-and-Time-for-First-Quarter-Fiscal-2023-Earnings-Release/ | CONSHOHOCKEN, Pa.--( BUSINESS WIRE )--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2023 on Wednesday, February 1, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the... | AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-02 10:32:06 | https://www.zacks.com/stock/news/2034301/want-better-returns-don-t-ignore-these-2-medical-stocks-set-to-beat-earnings | Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. | Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-12-29 16:45:00 | https://www.marketwatch.com/story/feds-sue-drug-wholesaler-amerisourcebergen-over-opioid-sales-01672350324 | HARRISBURG, Pa. — The U.S. Justice Department claimed in a lawsuit filed Thursday that a major drug wholesaler contributed to the deadly toll from opioids by turning a blind eye to warning signs about suspicious sales to its pharmacy customers. | Feds sue drug wholesaler AmerisourceBergen over opioid sales | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2022-12-28 14:03:57 | https://www.youtube.com/watch?v=6F7ZYoYQm1o | The "Halftime Report" traders give their top picks to watch for the second half. | Final Trades: American Water, Boeing, Danaher & more | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-26 09:30:00 | https://www.fool.com/investing/2022/12/26/buy-this-warren-buffett-stock-for-2023-and-beyond/ | This healthcare products distributor's business model can withstand a recession. | Buy This Warren Buffett-Owned Stock for 2023 and Beyond | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2022-12-19 12:00:31 | https://www.investors.com/etfs-and-funds/mutual-funds/how-to-invest-in-2023-hot-investors-brace-for-bumps/ | Want to know how to invest in 2023? Red-hot fund manager Dale Harvey says individual investors should fasten their seat belts. | Red-Hot Fund Managers Expect Rocky Start To 2023 | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2022-12-16 13:50:54 | https://www.youtube.com/watch?v=moinufkpB-8 | The "Halftime Report" traders give their top picks to watch for the second half. | Final Trades: UnitedHealth, AmerisourceBergen, Rockwell Automation & more | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-12 12:02:20 | https://www.zacks.com/stock/news/2027857/amerisourcebergen-abc-to-repurchase-common-stock-worth-200m | AmerisourceBergen (ABC) announces a share repurchase worth $200 million in concurrence with the sale of its shares by one of its shareholders, Walgreens Boots Alliance, under Rule 144. | AmerisourceBergen (ABC) to Repurchase Common Stock Worth $200M | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2022-11-29 12:28:46 | https://www.gurufocus.com/news/1900554/this-dividend-aristocrats-high-yield-looks-like-a-safe-haven | Investors shopping for income often begin by asking if a dividend, and particularly a high one, is sustainable. It's a logical and important question every investor should ask. | This Dividend Aristocrat's High Yield Looks Like a Safe Haven | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-11-28 14:17:06 | https://www.zacks.com/stock/news/2022987/amerisourcebergen-abc-hits-52-week-high-what-s-driving-it | Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business. | AmerisourceBergen (ABC) Hits 52-Week High: What's Driving It? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-11-22 15:48:07 | https://www.zacks.com/stock/news/2021125/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-11-09 11:18:01 | https://www.zacks.com/commentary/2016074/3-dental-supplies-stocks-to-watch-amid-industry-headwinds | Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, MCK and ABC. | 3 Dental Supplies Stocks to Watch Amid Industry Headwinds | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-11-03 13:33:19 | https://www.zacks.com/stock/news/2013553/amerisourcebergen-abc-q4-earnings-revenues-top-estimates | AmerisourceBergen's (ABC) fiscal fourth-quarter 2022 results benefit from segmental growth. | AmerisourceBergen (ABC) Q4 Earnings & Revenues Top Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-11-03 12:02:02 | https://seekingalpha.com/article/4552580-amerisourcebergen-corporation-abc-q3-2022-earnings-call-transcript | AmerisourceBergen Corporation (NYSE:ABC ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Bennett Murphy - SVP, IR Steven Collis - Chairman, President & CEO James Cleary - EVP & CFO Conference Call Participants Lisa Gill - JPMorgan Chase & Co. Michael Cherny - Bank of America Merrill L... | AmerisourceBergen Corporation (ABC) Q3 2022 Earnings Call Transcript | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-11-03 09:02:44 | https://www.zacks.com/stock/news/2013145/amerisourcebergen-abc-surpasses-q4-earnings-and-revenue-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.78% and 1.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Surpasses Q4 Earnings and Revenue Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-11-03 06:52:23 | https://www.marketwatch.com/story/amerisourcebergen-profit-falls-but-tops-estimates-for-q4-2022-11-03 | AmerisourceBergen Corp. ABC, -0.97% said Thursday it had net income of $294.7 million, or $1.40 a share, for its fiscal fourth quarter to Sept. 30, down from $437.7 million, or $2.08 a share, in the year-earlier period. | AmerisourceBergen profit falls but tops estimates for Q4 | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-11-02 00:14:47 | https://seekingalpha.com/article/4551809-importance-government-contracting-amerisourcebergen | AmerisourceBergen has won nearly $1.5bn in government contract awards in 2022 up until the end of Q3. 21.3% Y/Y adjusted EPS growth in Q3 2022 driven by strong operating performance & M&A. | The Importance Of Government Contracting For AmerisourceBergen | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-10-25 12:02:05 | https://www.zacks.com/stock/news/1996897/amerisourcebergen-abc-to-post-q4-earnings-what-s-in-store | AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment. | AmerisourceBergen (ABC) to Post Q4 Earnings: What's in Store? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-10-18 13:33:18 | https://www.zacks.com/stock/news/1993643/will-amerisourcebergen-abc-beat-estimates-again-in-its-next-earnings-report | AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-10-06 16:31:57 | https://seekingalpha.com/article/4545125-amerisourcebergen-corporation-looking-healthier | After a few years of stagnation, shares of AmerisourceBergen have come to life again. AmerisourceBergen is seeing solid growth, leverage is low, and opioid settlements have been announced. | AmerisourceBergen Corporation: Looking Healthier | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-09-28 07:15:00 | https://www.businesswire.com/news/home/20220927006084/en/AmerisourceBergen-Announces-Date-and-Time-for-Fourth-Quarter-Fiscal-2022-Earnings-Release/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2022 on Thursday, November 3, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the r... | AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Proactive Investors | 2022-09-27 10:10:11 | https://www.proactiveinvestors.com/companies/news/993772?SNAPI | Outlook Therapeutics Inc (NASDAQ:OTLK) said it has entered into a strategic relationship with healthcare company AmerisourceBergen in preparation for the anticipated commercial launch in the United States of its ONS-5010 treatment for wet age-related macular degeneration (AMD). ONS-5010 is an investigational ophthalmi... | Outlook Therapeutics enters into commercialization agreement with AmerisourceBergen | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-09-26 13:32:11 | https://www.zacks.com/stock/news/1984990/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-09-13 13:32:10 | https://www.zacks.com/stock/news/1980026/amerisourcebergen-abc-to-buy-germany-s-pharmalex-for-1-3b | AmerisourceBergen (ABC) inks a deal to acquire PharmaLex to support its goal to become a strategic partner of choice for pharma customers for clinical and commercial enablement solutions. | AmerisourceBergen (ABC) to Buy Germany's PharmaLex for $1.3B | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-09-12 08:23:23 | https://www.marketwatch.com/story/amerisourcebergen-agrees-to-acquire-germanys-pharmalex-for-128-billion-euros-in-cash-2022-09-12 | AmerisourceBergen Corp. ABC, -0.18% said Monday it has agreed to acquire PharmaLex Holding GmbH, a German company offering specialized services for the life sciences industry, or 1.28 billion euros ($1.29 billion) in cash. The deal "will advance AmerisourceBergen's role as partner of choice for biopharmaceutical manufa... | AmerisourceBergen agrees to acquire Germany's PharmaLex for 1.28 billion euros in cash | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-24 12:47:30 | https://www.zacks.com/stock/news/1971956/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2022-08-19 07:36:39 | https://www.investors.com/research/wba-stock-buy-now/ | Walgreens faces legal challenges as rising costs eat into profit margins. Is Walgreens stock a buy? | Is WBA Stock A Buy Or Sell After Pivotal Court Ruling In Opioids Case? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-08-16 11:50:08 | https://seekingalpha.com/article/4534842-back-to-the-future-with-amerisourcebergen-corporation | ABC has recently pulled back and provides a potential entry point for investors. Long term, the industry should maintain its 1% share of US expenditure on pharmaceuticals. The Inflation Reduction Act is mainly focused on Medicare Part D. ABC is more heavily exposed to Part B which will be impacted in 2028. | Back To The Future With AmerisourceBergen Corporation | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-15 14:18:06 | https://www.zacks.com/stock/news/1968271/is-amerisourcebergen-abc-a-solid-growth-stock-3-reasons-to-think-yes | AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market. | Is AmerisourceBergen (ABC) a Solid Growth Stock? 3 Reasons to Think "Yes" | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-15 06:01:05 | https://www.zacks.com/stock/news/1967986/beat-the-market-the-zacks-way-walt-disney-dis-amerisourcebergen-abc-c-h-robinson-worldwide-chrw-in-focus | Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week. | Beat the Market the Zacks Way: Walt Disney (DIS), AmerisourceBergen (ABC), C.H. Robinson Worldwide (CHRW) in Focus | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-10 11:17:43 | https://www.zacks.com/stock/news/1966620/has-amerisourcebergen-abc-outpaced-other-medical-stocks-this-year | Here is how AmerisourceBergen (ABC) and Aerie Pharmaceuticals (AERI) have performed compared to their sector so far this year. | Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-10 11:17:37 | https://www.zacks.com/stock/news/1966631/are-investors-undervaluing-amerisourcebergen-abc-right-now | Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | Are Investors Undervaluing AmerisourceBergen (ABC) Right Now? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-03 12:47:16 | https://www.zacks.com/stock/news/1963256/amerisourcebergen-abc-q3-earnings-revenues-top-estimates | AmerisourceBergen's (ABC) fiscal third-quarter results benefit from segmental growth. | AmerisourceBergen (ABC) Q3 Earnings & Revenues Top Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-08-03 11:51:04 | https://seekingalpha.com/article/4529147-amerisourcebergen-corp-abc-ceo-steven-collis-on-q3-2022-results-earnings-call-transcript | Amerisourcebergen Corp (NYSE:ABC ) Q3 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants Bennett Murphy - SVP, IR Steven Collis - Chairman, President & CEO James Cleary - EVP & CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Lisa Gill - JPMorgan Chase & Co. Eric Percher - Ne... | Amerisourcebergen Corp (ABC) CEO Steven Collis on Q3 2022 Results - Earnings Call Transcript | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-08-03 09:02:13 | https://www.zacks.com/stock/news/1962680/amerisourcebergen-abc-q3-earnings-and-revenues-surpass-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.95% and 1.47%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Q3 Earnings and Revenues Surpass Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-08-03 06:44:35 | https://www.marketwatch.com/story/amerisourcebergen-beats-profit-and-revenue-expectations-raises-full-year-outlook-2022-08-03 | AmerisourceBergen Corp. ABC, -2.14% reported Wednesday fiscal third-quarter profit and revenue that beat expectations and raised its full-year outlook, amid strength in its International Healthcare Solutions (IHS) business. Shares of the pharmaceuticals and healthcare products company were still inactive in premarket t... | AmerisourceBergen beats profit and revenue expectations, raises full-year outlook | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-07-27 12:25:13 | https://www.zacks.com/stock/news/1958969/is-a-beat-likely-for-amerisourcebergen-abc-in-q3-earnings | AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment. | Is a Beat Likely for AmerisourceBergen (ABC) in Q3 Earnings? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-07-12 16:59:06 | https://www.zacks.com/stock/news/1951330/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-06-29 16:15:00 | https://www.businesswire.com/news/home/20220629005895/en/AmerisourceBergen-Announces-Date-and-Time-for-Third-Quarter-Fiscal-2022-Earnings-Release/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2022 on Wednesday, August 3, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the res... | AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-06-16 09:30:22 | https://seekingalpha.com/article/4518746-why-amerisourcebergen-is-the-best-in-class-pharmaceuticals-distributor | AmerisourceBergen is one of the "big three" distributors of pharmaceuticals in the United States. In terms of 2021 revenues, it is almost as big as McKesson. The business is recession-resistant, and because it has high barriers to entry due to its heavy regulation and sophisticated distribution networks. AmerisourceBer... | Why AmerisourceBergen Is The Best-In-Class Pharmaceuticals Distributor | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-06-07 12:02:15 | https://www.zacks.com/stock/news/1935610/here-s-why-you-should-retain-amerisourcebergen-abc-stock | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Here's Why You Should Retain AmerisourceBergen (ABC) Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-06-03 12:49:22 | https://www.zacks.com/stock/news/1934075/why-is-amerisourcebergen-abc-down-4-5-since-last-earnings-report | AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? | Why Is AmerisourceBergen (ABC) Down 4.5% Since Last Earnings Report? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-06-01 06:39:08 | https://www.marketwatch.com/story/amerisourcebergen-sets-1-billion-stock-buyback-program-2022-06-01 | AmerisourceBergen Corp. ABC, -1.32% said Wednesday that it set a new $1 billion stock repurchase program. That represents 3.1% of the pharmaceutical and health care products company's market capitalization of $32.42 billion at Tuesday's stock closing price. | AmerisourceBergen sets $1 billion stock buyback program | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-05-30 10:00:00 | https://seekingalpha.com/article/4515307-amerisourcebergen-healthy-wealthy-stock | AmerisourceBergen is a leading global drug distributor with a strong focus on operational excellence. The company has recently resolved the majority of its legal troubles related to the Opioid crisis, and is now free to continue growing its business. | AmerisourceBergen: A Healthy, Wealthy Stock You Can Count On | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-05-12 11:06:00 | https://www.marketwatch.com/story/amerisourcebergens-stock-tanks-after-largest-investor-sells-900-million-worth-of-shares-11652367963 | Shares of AmerisourceBergen Corp. suffered the biggest selloff in more than two years on Thursday, after the drug products and distribution company's largest investor sold off a chunk of its stake. | AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2022-05-12 07:37:05 | https://www.benzinga.com/news/large-cap/22/05/27158624/walgreens-boots-alliance-cuts-its-stake-in-amerisourcebergen | Walgreens Boots Alliance Inc (NASDAQ: WBA) has sold 6.0 million shares of AmerisourceBergen Corp (NYSE: ABC) at $150 per share. After the sale, Walgreens Boots Alliance's ownership of AmerisourceBergen's common stock decreased from approximately 28.1% to 25.2%. | What's Going On With AmerisourceBergen Shares Today | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-04 11:17:30 | https://www.zacks.com/stock/news/1915616/amerisourcebergen-abc-q2-earnings-revenues-top-estimates | AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth. | AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-05-04 10:10:03 | https://seekingalpha.com/article/4506722-amerisourcebergen-corporation-abc-ceo-steve-collis-on-q2-2022-results-earnings-call | AmerisourceBergen Corporation (NYSE:ABC ) Q2 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President-Investor Relations Steve Collis - Chairman, President & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Pa... | AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q2 2022 Results - Earnings Call Transcript | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-05-04 09:02:14 | https://www.zacks.com/stock/news/1915156/amerisourcebergen-abc-tops-q2-earnings-and-revenue-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.69% and 0.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Tops Q2 Earnings and Revenue Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-05-04 06:51:31 | https://www.marketwatch.com/story/amerisourcebergen-beats-earnings-expectations-and-lifts-full-year-guidance-2022-05-04 | AmerisourceBergen Corp. ABC, +1.20% reported first-quarter profit and revenue that rose above expectations, amid strength in international healthcare business, and raised its full-year outlook. The health care services company's stock was still inactive in premarket trading. | AmerisourceBergen beats earnings expectations, and lifts full-year guidance | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-04-27 16:50:08 | https://www.zacks.com/stock/news/1909513/amerisourcebergen-abc-reports-next-week-wall-street-expects-earnings-growth | AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | AmerisourceBergen (ABC) Reports Next Week: Wall Street Expects Earnings Growth | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-04-11 13:33:32 | https://www.zacks.com/stock/news/1897195/amerisourcebergen-s-abc-venture-capital-fund-to-aid-healthcare | AmerisourceBergen's (ABC) new corporate venture capital fund to help emerging healthcare startup companies change healthcare for people and animals globally. | AmerisourceBergen's (ABC) Venture Capital Fund to Aid Healthcare | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-04-04 11:18:28 | https://www.zacks.com/stock/news/1892426/here-s-why-you-should-retain-amerisourcebergen-abc-stock | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. | Here's Why You Should Retain AmerisourceBergen (ABC) Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-03-28 16:40:00 | https://www.businesswire.com/news/home/20220328005858/en/AmerisourceBergen-Announces-Date-and-Time-for-Second-Quarter-Fiscal-2022-Earnings-Release-Announces-2022-Investor-Day/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2022 on Wednesday, May 4, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the resul... | AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MarketBeat | 2022-03-25 04:00:54 | https://www.marketbeat.com/originals/3-health-care-stocks-with-healthy-fundamentals/?SNAPI?SNAPI | These three fundamentally sound companies will protect both your vitals and your financial livelihood for years to come. | 3 Healthcare Stocks With Healthy Fundamentals | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-03-16 11:17:39 | https://www.zacks.com/stock/news/1882783/is-amerisourcebergen-abc-outperforming-other-medical-stocks-this-year | Here is how AmerisourceBergen (ABC) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year. | Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.